median overall survival

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

median overall survival

Dec 9, 2024, 13:18 | Insight

Pembrolizumab vs chemotherapy in MSI-high or MMR-deficient metastatic colorectal cancer

Shivani Modi shared a post on X: "Talk of the town! KEYNOTE-177 trial shows mFU: 73.3…

Jun 27, 2024, 02:53 | Blog

Tanja Obradovic: Tempest Therapeutics just announced very good results from ongoing global clinical study with Amezalpat

Tanja Obradovic shared on LinkedIn: . “Are we to expect completely new mechanism of action…

Jun 18, 2024, 07:07 | Insight

Tislelizumab plus chemotherapy in advanced gastric/GEJ adenocarcinoma

Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X: "Tislelizumab plus chemotherapy vs…

Jun 7, 2024, 13:10 | Opinion

Paolo Tarantino: Among the ASCO24 abstracts, particularly notable was the DB03 update

Erika Hamilton shared Paolo Tarantino's post on X, adding: , "Agree, I…

May 24, 2024, 13:24 | Insight

Erman Akkus Summarizes 5-year Results of CheckMate 040

Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X: “Nivolumab plus ipilimumab…

All: 5 Posts: 1 - 100

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

'

King Charles III Hospitalized Following Side Effects from Cancer Treatment

'

Keith T. Flaherty has been elected as the AACR President-Elect for 2025-2026

'

MARIPOSA trial results presented at ELCC25 - BREAKING from Paris

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023